China's appetite for acquiring overseas companies was dealt a major setback this week as regulatory fears hindered two potential takeovers. How will this affect the $44bn ChemChina deal to acquire Swiss agribusiness Syngenta and other large-scale deals? US M&A correspondent James Fontanella-Khan explains.

iTunes Stitcher audioBoom SoundCloud Overcast RSS

Copyright The Financial Times Limited 2017. All rights reserved.

Follow the topics related to this show

Comments have not been enabled for this podcast.